The 12 closest competitors and alternatives to Profound Medical Corp. among medical devices companies — ranked by similarity to what Profound Medical Corp. actually does, not by market-cap band.
Subscribe to see Profound Medical Corp.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Profound Medical Corp., through its subsidiaries, is a commercial-stage medical technology firm specializing in the development of magnetic resonance (MR)-guided ablation solutions. These innovative procedures are designed to treat conditions such as prostate disease and uterine fibroids, as well as providing palliative pain relief. The company markets its solutions across Canada, Germany, the United States, and Finland. Its flagship product, the TULSA-PRO system, is specifically designed for use with magnetic resonance imaging (MRI) scanners within hospital settings and other treatment centers. Additionally, Profound Medical offers Sonalleve, a therapeutic platform that addresses uterine fibroids – including through non-invasive methods – and provides palliative relief for pain linked to bone metastases. The company's primary operations are headquartered in Mississauga, Canada.
Profound Medical Corp. is a medical devices company headquartered in Mississauga, Canada. It is publicly listed (PROF) with a market capitalisation of $207.3M. Xcout tracks 15 named people at Profound Medical Corp., including Arun Swarup Menawat (Chairman of the Board & Chief Executive Officer). Xcout recorded 3 job postings from Profound Medical Corp. in the last 90 days.
9 more named people on record for Profound Medical Corp., with roles, board committees and tenure — see the full roster →
Xcout recorded 3 job postings from Profound Medical Corp. in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Profound Medical Corp.'s hiring signals →
Ranked by semantic similarity — how close each company is to Profound Medical Corp. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Medical Device
Focal Medical develops and manufactures the Focal One HIFU Robotic System, a non-invasive medical device that utilizes high-intensity focused ultrasound technology to precisely target and ablate prostate tissue. The company serves urologists and healthcare facilities by providing equipment for prostate cancer management that preserves healthy surrounding tissue and minimizes side effects for patients.
Similar medical devices company
Gynesonics, Inc. is a U.S. medical-device company that develops minimally invasive, incision-free treatments for uterine fibroids. Its Sonata System uses transcervical radiofrequency ablation with intrauterine ultrasound guidance and serves gynecologists and women seeking fibroid treatment.
Medical - Devices
PROCEPT BioRobotics Corporation specializes in pioneering surgical robotic technologies, offering innovative solutions within the field of urology. Its flagship product is the AquaBeam Robotic System, a sophisticated, image-guided surgical robot designed for minimally invasive urological procedures. This system primarily facilitates Aquablation therapy, which the company also devised, to alleviate lower urinary tract symptoms in male patients diagnosed with benign prostatic hyperplasia (BPH). As of year-end 2021, PROCEPT BioRobotics had successfully deployed 130 AquaBeam Robotic Systems across the globe, with a significant majority—78 units—located in the United States. Founded in 2007, the corporation maintains its headquarters in Redwood City, California.
Similar medical devices company
IMRIS Inc. designs and manufactures innovative intraoperative MRI systems and surgical imaging solutions, including ceiling-mounted rail systems that bring diagnostic imaging directly to the patient during neurosurgery. The company also provides comprehensive operating suite design, installation, and clinical support services for healthcare facilities.
Medical Device
Focal Therapeutics provides the Focal One robotic system, which utilizes high-intensity focused ultrasound (HIFU) technology to non-invasively target and ablate prostate tissue for prostate cancer patients. The system is designed for urologists to precisely treat targeted lesions while sparing healthy surrounding tissue and minimizing side effects.
Similar medical devices company
EDAP TMS S.A. operates as a holding company, with its subsidiary primarily focused on the innovation, manufacturing, and distribution of advanced, minimally invasive medical devices engineered to address urological conditions. The company's activities are organized into two principal divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU segment is dedicated to the creation, production, and commercialization of devices that employ HIFU technology for the precise, non-surgical elimination of certain localized tumors. In contrast, the UDS division concentrates on the entire lifecycle—from development and marketing to manufacturing and servicing—of medical instruments used for the minimally invasive diagnosis and treatment of various urological disorders, particularly urinary stones and other related clinical indications. This enterprise was founded on December 3, 1979, and its corporate headquarters are located in Vaulx-en-Velin, France.
Similar medical devices company
Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically for breast tumors.
Similar medical devices company
Francis Medical, Inc. develops medical technology for targeted tissue ablation, including the Vanquish System designed for water vapor prostate treatment.
Similar medical devices company
Covalon Technologies Ltd., a Canadian company based in Mississauga, innovates, develops, manufactures, and commercializes medical technologies and products globally. Its operations span major international markets, including North America, Europe, the Middle East, Asia, and Latin America, with licensing agreements in place. The company leverages three distinct proprietary technology platforms. Firstly, its collagen matrix platform underpins a family of products aimed at treating a variety of chronic and infected wounds, such as diabetic, pressure, and venous ulcers, as well as donor and graft sites, traumatic injuries healing by secondary intention, dehisced surgical wounds, and first- and second-degree burns. Secondly, an antimicrobial silicone adhesive platform is incorporated into pre- and post-surgical and vascular access products; these are specifically engineered to provide broad-spectrum antimicrobial protection by eliminating bacteria or yeast on contact. Thirdly, a unique medical coating platform employs a proprietary photo-polymerization process to generate active grafting sites, enabling the initiation and growth of new polymer chains directly on existing medical devices. Covalon's product portfolio, branded under "Covalon," encompasses advanced wound care dressings, surgical and peri-operative solutions, and infection management tools. These offerings reach a diverse clientele, including hospitals, specialized wound and burn centers, acute and long-term care facilities, home health care agencies, and physicians' offices, via a combination of direct sales and extensive third-party distribution networks.
Similar medical devices company
MedicaMetrix develops medical devices for prostate health, specifically offering the ProstaMetrix platform to measure prostate volume and calculate Prostate Specific Antigen Density (PSAD) during routine clinical examinations. The company serves urologists and healthcare professionals by providing tools for the early detection and ongoing monitoring of prostate conditions such as prostate cancer and BPH.
Similar medical devices company
Sonendo, Inc. operates as a commercial-stage medical technology firm, dedicated to innovating, producing, and marketing advanced devices for root canal treatment across the United States and Canada. A flagship offering is GentleWave, an innovative device for addressing tooth decay that meticulously cleans and sanitizes the intricate microscopic passages within teeth without the need for removing any natural tooth structure. The company's product line also features SoundSeal, a specialized material used to construct and seal dental crowns, alongside its proprietary Sonendo-branded liquid solution of EDTA, which assists in the debridement and disinfection processes crucial for root canal systems. Furthermore, Sonendo provides "The Digital Office," a comprehensive practice management software solution designed to foster an integrated digital environment for dental professionals. Established in 2006, the organization was initially known as Dentatek Corporation before officially rebranding to Sonendo, Inc. in March 2011. Its corporate headquarters are situated in Laguna Hills, California.
Similar medical devices company
Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions. The organization was established in 2012, with its corporate headquarters situated in Guangzhou, China.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Profound Medical Corp.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →